Sugi Predict

Sugi Predict / Compounds / SCHEMBL2258563

SCHEMBL2258563

SCHEMBL2258563

CCS(=O)(=O)N[C@H]1CC[C@H](Nc2ncc3cccc(OC4CCOCC4)c3n2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.42
▸ JAK1 P23458 2/20 0.42
▸ TYK2 P29597 2/20 0.42
▸ JAK3 P52333 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ MAPK14 Q16539 9/20 0.40
▸ MAPK8 P45983 4/20 0.40
▸ TTK P33981 1/20 0.39
▸ MAPK10 P53779 3/20 0.39
▸ JUN P05412 1/20 0.39
▸ TNIK Q9UKE5 1/20 0.39
▸ PIK3CD O00329 1/20 0.38
▸ PIK3R1 P27986 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ MAPK9 P45984 2/20 0.38
▸ CDK1 P06493 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2258568 1.00 JAK2 (0.42) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL2259636 0.94 JAK2 (0.39) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL2259638 0.94 JAK2 (0.39) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL2262354 0.90 PIK3CD (0.46) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL2262359 0.90 PIK3CD (0.46) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL559614 0.87 JAK2 (0.44) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL559616 0.87 JAK2 (0.44) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL558086 0.87 JAK2 (0.47) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL558802 0.85 MAPK1 (0.45) JAK2JAK1TYK2JAK3MAPK1
SCHEMBL558801 0.85 MAPK1 (0.45) JAK2JAK1TYK2JAK3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 — — US disclosed
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 — — US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 — — US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 — — US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 — — US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 — — US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 — — US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 JAK2 54/4885JAK1 87/4885TYK2 1929/4885
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 JAK2 54/4885JAK1 87/4885TYK2 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.